Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
RQ-00000010
print preview
bookmark
share with colleague
General Information
Company
RaQualia Pharma Inc.
Description
Serotonin 5-HT4 partial agonist
Molecular Target
Serotonin (5-HT4) receptor
Mechanism of Action
Serotonin (5-HT4) receptor agonist
Latest Stage of Development
Phase I
Indication
Gastroesophageal reflux disease (GERD)
Partner
CJ Group
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy